EUVIMEDEUVIMED entdecken
Crossref

Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program

Benyam Muluneh, Molly Schneider, Aimee Faso, Lindsey Amerine, Rowell Daniels, Brett Crisp, John Valgus, Scott Savage

Journal of Oncology Practice · 2018-06 · 14 (6) · e324-e334

DOI: 10.1200/jop.17.00039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oncology Practice, 2018-06. Verfasst von Benyam Muluneh und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of North Carolina (UNC) at Chapel Hill; UNC Medical Center, Chapel Hill, NC; and Ralph H. Johnson Veterans Affairs Medical Center, Charles…. Hauptthemen laut MEDLINE: Delivery of Health Care, Integrated, Medication Adherence, Medication Therapy Management, Outcome Assessment, Health Care. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To address the growing use of oral anticancer therapy, an integrated, closed-loop, pharmacist-led oral chemotherapy management program was created within an academic medical center.

Methods

An integrated, closed-loop, pharmacy-led oral chemotherapy management program was established. From September 2014 until June 2015, demographic information, rates of adherence, patient understanding of treatment, pharmacist interventions, patient and provider satisfaction, and molecular response rates in patients with chronic myeloid leukemia (CML) were collected.

Results

After full implementation, 107 patients were enrolled in our oral chemotherapy management program from September 2014 until June 2015. All patients were educated before starting oral chemotherapy, and using pre- and postassessment tests, comprehension of oral chemotherapy treatment increased from 43% to 95%. Patient-reported adherence was 86% and 94.7% for the GI/breast and malignant hematology patient populations, respectively, and these were validated with medication possession ratio, revealing adherence rates of 85% and 93.9% for the GI/breast and malignant hematology patient populations, respectively. A total of 350 encounters with a clinical pharmacist and 318 adverse effects were reported, which led to 235 interventions. This program led to a higher major molecular response rate (83%) in our CML population compared with published clinical trials (average major molecular response rates, 40% and 60% with 1- and 2-year follow-up, respectively).

Conclusion

An innovative model was developed and resulted in improved patient knowledge regarding oral chemotherapy, improved adherence rates that exceeded nationally established thresholds, and superior major molecular response outcomes for patients with CML compared with published literature. As a result, this model has produced the gold standard in managing patients receiving oral chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Delivery of Health Care, IntegratedMedication AdherenceMedication Therapy ManagementOutcome Assessment, Health CarePharmacistsProfessional RoleAdministration, OralAntineoplastic AgentsDisease ManagementFemaleHumansMaleNeoplasmsPatient Education as TopicPatient SatisfactionPharmaceutical ServicesQuality ImprovementTreatment Outcome

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • University of North Carolina (UNC) at Chapel Hill; UNC Medical Center, Chapel Hill, NC; and Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC.

Zitieren

APA

Muluneh, B., Schneider, M., Faso, A., Amerine, L., Daniels, R., Crisp, B., Valgus, J., & Savage, S. (2018). Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program. Journal of Oncology Practice, 14(6), e324-e334. https://doi.org/10.1200/jop.17.00039

Vancouver

Muluneh B, Schneider M, Faso A, Amerine L, Daniels R, Crisp B, et al. Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program. Journal of Oncology Practice. 2018;14(6):e324-e334. doi:10.1200/jop.17.00039

BibTeX
@article{Muluneh2018,
  author = {Muluneh, Benyam and Schneider, Molly and Faso, Aimee and Amerine, Lindsey and Daniels, Rowell and Crisp, Brett and Valgus, John and Savage, Scott},
  title = {Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program},
  journal = {Journal of Oncology Practice},
  year = {2018},
  volume = {14},
  number = {6},
  pages = {e324--e334},
  doi = {10.1200/jop.17.00039}
}
Kostenlos starten →